Furthermore, Claire is currently defining how these therapies molecularly reprogram immune cells prior to and after stimulation. Pillsbury says the immune dysregulation that occurs in cancer patients living with obesity allows for the unchecked outgrowth of some cancers because the immune system is more exhausted and less responsive to foreign invaders
Lose 15% of your body weight with GLP-1s * Lose 15% of your body weight with GLP-1s * *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group
Martha Viera, MD References National Library of Medicine, 2024, Glucagon-Like Peptide-1 Receptor Agonists Sofwave, Lost Weight, Gained Loose Skin or Muscle Loss
Supplementary information Supplementary Table 1 (download XLSX Sample sizes ( n ) and statistical significance values ( P values) for all data panels in the study
New neurological symptoms
